YD Bio Ltd files 6-K

YD Bio Limited filed a Form 6-K on September 30, 2025, containing unaudited interim financial statements for YD Bio Limited, YD Biopharma Limited, and Breeze Holdings Acquisition Corp., along with related management discussions and analysis. The filing also includes unaudited pro forma condensed combined and consolidated financial information and a press release dated September 30, 2025.